Literature DB >> 17336072

IL-10, T cell exhaustion and viral persistence.

Shawn D Blackburn1, E John Wherry.   

Abstract

Viral infections can have one of two outcomes: control of viral replication and acute infection or viral persistence and chronic infection. It is clear that both pathogen and host characteristics influence the acute versus chronic outcome of viral infection. The early events in the host immune response that favor immunosuppression and viral persistence, however, have remained poorly understood. Using the well-characterized mouse model of acute versus chronic lymphocytic choriomeningitis virus (LCMV) infection, two groups have recently identified the interleukin-10 (IL-10)/IL-10R pathway as a key regulator of acute versus chronic infection. Blockade of IL-10R converted a chronic LCMV infection into a rapidly controlled acute viral infection and prevented the functional exhaustion of memory T cells. These insights into the role of IL-10 in the establishment of chronic infection could lead to new therapeutic opportunities during human infections with pathogens such as HIV, hepatitis C virus (HCV) and hepatitis B virus (HBV).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336072     DOI: 10.1016/j.tim.2007.02.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  105 in total

1.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

2.  Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Authors:  Noelle D Brodeur; Juliet V Spencer
Journal:  Virus Res       Date:  2010-08-20       Impact factor: 3.303

3.  The characteristics of NK cells in Schistosoma japonicum-infected mouse spleens.

Authors:  Lu Li; Hefei Cha; Xiuxue Yu; Hongyan Xie; Changyou Wu; Nuo Dong; Jun Huang
Journal:  Parasitol Res       Date:  2015-08-29       Impact factor: 2.289

Review 4.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

5.  Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.

Authors:  Shih-Wen Lin; Scott E Hensley; Nia Tatsis; Marcio O Lasaro; Hildegund C J Ertl
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection.

Authors:  David G Brooks; Sang-Jun Ha; Heidi Elsaesser; Arlene H Sharpe; Gordon J Freeman; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 7.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function.

Authors:  Gang Cai; Xiaomeng Nie; Lei Li; Liang Hu; Beiying Wu; Jiafei Lin; Cen Jiang; Huaizhou Wang; Xuefeng Wang; Qian Shen
Journal:  J Gastroenterol       Date:  2013-03-27       Impact factor: 7.527

Review 9.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

Review 10.  Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection.

Authors:  Christoph Neumann-Haefelin; Hans-Christian Spangenberg; Hubert-E Blum; Robert Thimme
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.